Diabetes patients have long been in search of virtually painless insulin injection.
Terumo has made this possible with the advanced NANOPASS 34 - the world’s thinnest pen needle* with a diameter of only 34G.
NANOPASS 34G reduces pain through several advanced technologies.
*Based on research by Terumo Corporation in May 2016
NANOPASS 34 is 22% thinner than 32G.
The unique asymmetric edge of NANOPASS cuts the skin instead of puncturing it.
This decreases the resistance while penetrating the skin. Another step towards virtually painless insulin injection.
The patented slim double tapered needle shape reduces the insulin injection force significantly.
Although the needle end is 34G, NANOPASS 34 provides less injection force than a conventional 32G pen needle*.
NANOPASS 34 combines virtually painless injection with easy handling.
* Intra company data
Nanopass®34G is not sold in North America.
Please note that some products may not be available in all regions, check with your local TERUMO Pharmaceuticals Solutions contact for details.
The device has no components made of natural rubber latex.